Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 57

Results For "formulation"

801 News Found

JBCL rebrands as JB
News | May 29, 2022

JBCL rebrands as JB

JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India


DFE Pharma opens its new Center of Excellence in Hyderabad, India
News | May 27, 2022

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs


Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections
News | May 24, 2022

Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections

'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)


Soligenix receives US patent allowance for its thermostabilized vaccine platform
Biotech | May 23, 2022

Soligenix receives US patent allowance for its thermostabilized vaccine platform

Includes thermostabilized Ebola vaccines


Glenmark Pharma gets observations from USFDA for its Goa and Monroe facilities
News | May 22, 2022

Glenmark Pharma gets observations from USFDA for its Goa and Monroe facilities

A total of five observations for Goa and 17 for Monroe


Propanc Biopharma undertaking PRP manufacturing & development for human use
Biotech | May 20, 2022

Propanc Biopharma undertaking PRP manufacturing & development for human use

PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection


Pfizer and BioNTech granted U.S. EUA for booster dose for kids 5-11 years
Drug Approval | May 18, 2022

Pfizer and BioNTech granted U.S. EUA for booster dose for kids 5-11 years

Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series


BDR Pharma receives Rs. 685 crore of PE investment
News | May 17, 2022

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company


Moderna announces advancements in mRNA platform science for application across multiple diseases
Biotech | May 17, 2022

Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery